JNCI Journal of the National Cancer Institute · 1975 · 63 citations · 0 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyMetastasisAntitumor T Cell ResponsesCancer ImmunotherapyCell-based ImmunotherapyImmunotherapy For Solid TumorsT Cell Responses To TumorsTumor-infiltrating LymphocytesCancer ImmunostimulationImmune System InteractionsImmune System ModulationImmuno-oncology ModelsImmunotherapy In Spontaneous ModelsLocal Tumor ProgressionLocal Tumor ResectionSensitization
To learn whether tumor metastases can be prevented by the immune system, we developed a model for the treatment of mice with syngeneic lymphocytes sensitized against tumor cells in vitro. Mice were given subcutaneously tumor cells that spontaneously metastasized to the lungs. The tumors developing locally were surgically removed and the mice were inoculated with sensitized lymphocytes 1 day later. Prevention of death by lung metastases was the measure of immunotherapy. Only approximately equal to 30-40 percent of mice receiving control treatment survived, whereas approximately equal to 70 percent survived that received lymphocytes sensitized in vitro against the tumor cells. Hence sensitization of syngeneic lymphocytes against tumor cells in vitro and injection of the lymphocytes into the host after removal of a local tumor prevented the development of lethal metastases.